Menu
GeneBe

RLN2

relaxin 2, the group of Neuropeptides

Basic information

Region (hg38): 9:5299863-5304716

Links

ENSG00000107014NCBI:6019OMIM:179740HGNC:10027Uniprot:P04090AlphaFoldGenCCjaxSfariGnomADPubmed

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the RLN2 gene.

  • Inborn genetic diseases (10 variants)
  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the RLN2 gene is commonly pathogenic or not.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous 0
missense 7 2 1 10
nonsense 1 1
start loss 0
frameshift 0
inframe indel 0
splice variant 0
non coding 0
Total 0 0 8 2 1

Variants in RLN2

This is a list of pathogenic ClinVar variants found in the RLN2 region.

Position Type Phenotype Significance ClinVar
9-5300174-C-G Inborn genetic diseases Uncertain significance (Oct 20, 2021)link
9-5300183-C-G Inborn genetic diseases Uncertain significance (Aug 10, 2021)link
9-5300223-G-A Inborn genetic diseases Uncertain significance (Oct 26, 2021)link
9-5300268-T-C Benign (Aug 16, 2018)link
9-5300316-G-C Inborn genetic diseases Uncertain significance (May 09, 2023)link
9-5300385-C-G Inborn genetic diseases Uncertain significance (Sep 15, 2021)link
9-5300414-G-A Inborn genetic diseases Uncertain significance (Dec 20, 2021)link
9-5304384-G-C Inborn genetic diseases Uncertain significance (Sep 22, 2022)link
9-5304394-G-C Inborn genetic diseases Uncertain significance (May 11, 2022)link
9-5304462-A-G Inborn genetic diseases Uncertain significance (Jul 05, 2023)link
9-5304505-A-T Inborn genetic diseases Uncertain significance (Oct 29, 2021)link
9-5304507-T-G Inborn genetic diseases Likely benign (Oct 29, 2021)link
9-5304563-A-C Inborn genetic diseases Likely benign (Oct 04, 2022)link

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
RLN2protein_codingprotein_codingENST00000381627 25102
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0009000.3621168160121168280.0000514
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-1.3213699.11.370.000005051201
Missense in Polyphen3731.3141.1816395
Synonymous-0.7484438.11.150.00000203353
Loss of Function-0.44343.151.271.37e-736

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.0004070.000407
Finnish0.000.00
European (Non-Finnish)0.00002800.0000278
Middle Eastern0.0004070.000407
South Asian0.00007570.0000745
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Relaxin is an ovarian hormone that acts with estrogen to produce dilatation of the birth canal in many mammals. May be involved in remodeling of connective tissues during pregnancy, promoting growth of pubic ligaments and ripening of the cervix.;
Pathway
Relaxin signaling pathway - Homo sapiens (human);Signaling by GPCR;Signal Transduction;G alpha (s) signalling events;Relaxin receptors;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;GPCR downstream signalling (Consensus)

Intolerance Scores

loftool
0.495
rvis_EVS
0.35
rvis_percentile_EVS
74.37

Haploinsufficiency Scores

pHI
0.214
hipred
N
hipred_score
0.112
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.0851

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Rln1
Phenotype
endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype;

Gene ontology

Biological process
G protein-coupled receptor signaling pathway;female pregnancy;regulation of signaling receptor activity;positive regulation of gene expression;positive regulation of angiogenesis;regulation of catalytic activity
Cellular component
extracellular region
Molecular function
hormone activity